SeekingAlpha · Aug 14, 2026
BillionToOne, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-14. The following slide deck was published by BillionToOne, Inc.
BL
NASDAQ · BLLN
BillionToOne, Inc.
Healthcare · Medical - Diagnostics & Research
$87.99
Up+$4.42 (+5.02%)
Updated Aug 19, 2026, 5:05 PM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.42B
- P/E ratio
- -142.14
- Dividend yield
- 0.00%
- 52-week range
- $61.96 – $150.44
- Volume
- 526.44K
- Avg. volume
- 256.93K
Price performance
BLLN price history
1M range · 21 trading sessions · Daily adjusted prices
BLLN closed at $87.99 after 21 trading sessions, down 33.61% for the selected period.
- Last close
- $87.99
- Period change
- -33.61%
- Period low
- $87.99
- Period high
- $149.97
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $93.12 | $94.315 | $87.96 | $87.99 | 526.44K |
| Aug 17, 2026 | $93.19 | $96.50 | $93.08 | $93.91 | 490.4K |
| Aug 14, 2026 | $94.14 | $95.28 | $91.90 | $93.33 | 480.99K |
| Aug 13, 2026 | $97.46 | $98.50 | $93.29 | $94.04 | 832.83K |
| Aug 12, 2026 | $97.99 | $98.94 | $96.00 | $97.45 | 522.86K |
| Aug 11, 2026 | $97.64 | $99.07 | $94.45 | $97.94 | 575.38K |
| Aug 10, 2026 | $93.00 | $99.53 | $92.00 | $98.65 | 892.14K |
| Aug 7, 2026 | $92.28 | $94.73 | $88.81 | $93.39 | 1.53M |
| Aug 6, 2026 | $105.16 | $105.35 | $90.1208 | $91.65 | 3.75M |
| Aug 5, 2026 | $142.07 | $150.44 | $141.35 | $149.97 | 922.06K |
| Aug 4, 2026 | $138.01 | $144.275 | $136.315 | $142.25 | 657.53K |
| Aug 3, 2026 | $138.11 | $139.88 | $132.00 | $137.32 | 843.23K |
| Jul 31, 2026 | $140.21 | $140.21 | $134.73 | $138.60 | 531.14K |
| Jul 30, 2026 | $130.86 | $140.00 | $130.86 | $139.59 | 515.54K |
| Jul 29, 2026 | $132.21 | $136.59 | $128.00 | $132.52 | 611.01K |
| Jul 28, 2026 | $127.64 | $134.98 | $125.09 | $133.64 | 807.36K |
| Jul 27, 2026 | $129.53 | $131.67 | $124.91 | $127.98 | 480.07K |
| Jul 24, 2026 | $130.00 | $130.00 | $123.85 | $126.08 | 479.11K |
| Jul 23, 2026 | $128.95 | $133.00 | $126.35 | $128.94 | 463.12K |
| Jul 22, 2026 | $132.33 | $133.66 | $126.57 | $129.24 | 533.5K |
| Jul 21, 2026 | $124.02 | $133.4599 | $123.96 | $132.53 | 561.57K |
Latest BLLN news
The latest Smart Investors Daily articles mentioning BLLN.
Stock researchCompany · Overview
BLLN research
Overview
Company profile and research snapshot.
Company profile
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $136.40
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | BTIG | Buy | — |
| Jun 29, 2026 | Guggenheim | Buy | — |
| May 13, 2026 | Guggenheim | Buy | — |
| May 7, 2026 | JP Morgan | Overweight | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 7, 2026
BillionToOne: A Softer Quarter After Heightened Expectations
Benzinga · Aug 6, 2026
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC) stock rose
Benzinga · Aug 6, 2026
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's pre-market session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC) shares
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
